Correlation Between Citigroup and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Exagen Inc, you can compare the effects of market volatilities on Citigroup and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Exagen.

Diversification Opportunities for Citigroup and Exagen

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Citigroup and Exagen is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Citigroup i.e., Citigroup and Exagen go up and down completely randomly.

Pair Corralation between Citigroup and Exagen

Taking into account the 90-day investment horizon Citigroup is expected to generate 4.38 times less return on investment than Exagen. But when comparing it to its historical volatility, Citigroup is 3.23 times less risky than Exagen. It trades about 0.25 of its potential returns per unit of risk. Exagen Inc is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  261.00  in Exagen Inc on August 28, 2024 and sell it today you would earn a total of  144.00  from holding Exagen Inc or generate 55.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  Exagen Inc

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Citigroup and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Exagen

The main advantage of trading using opposite Citigroup and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Citigroup and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories